BENEDETTI, LUANA
 Distribuzione geografica
Continente #
EU - Europa 2.659
NA - Nord America 874
AS - Asia 674
Continente sconosciuto - Info sul continente non disponibili 126
SA - Sud America 56
AF - Africa 13
OC - Oceania 2
Totale 4.404
Nazione #
IT - Italia 2.585
US - Stati Uniti d'America 821
SG - Singapore 253
CN - Cina 137
VN - Vietnam 131
BD - Bangladesh 58
HK - Hong Kong 38
BR - Brasile 30
CA - Canada 23
FR - Francia 23
JP - Giappone 12
AR - Argentina 10
MX - Messico 10
DE - Germania 9
FI - Finlandia 7
IN - India 7
JM - Giamaica 7
EC - Ecuador 6
IQ - Iraq 6
ID - Indonesia 5
PK - Pakistan 5
PL - Polonia 5
GB - Regno Unito 4
NL - Olanda 4
AZ - Azerbaigian 3
CL - Cile 3
HN - Honduras 3
KE - Kenya 3
MA - Marocco 3
PH - Filippine 3
UA - Ucraina 3
AT - Austria 2
AU - Australia 2
BZ - Belize 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
CY - Cipro 2
IE - Irlanda 2
IR - Iran 2
MD - Moldavia 2
RO - Romania 2
SC - Seychelles 2
SV - El Salvador 2
TR - Turchia 2
TW - Taiwan 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.278
Città #
Genoa 1.554
Vado Ligure 372
Genova 357
Rapallo 177
Singapore 136
San Jose 113
Ho Chi Minh City 44
Ashburn 35
Hong Kong 35
Beijing 24
New York 24
Hanoi 22
Lauterbourg 21
Santa Clara 21
Bordighera 18
Council Bluffs 17
Milan 17
Los Angeles 15
Houston 12
St Louis 12
Tokyo 12
Boardman 11
Buffalo 11
Rome 11
Atlanta 7
Chicago 7
Phoenix 7
Dallas 6
Frankfurt am Main 6
Helsinki 6
Kingston 6
Louisville 6
Milwaukee 6
Biên Hòa 5
Haiphong 5
Mexico City 5
Philadelphia 5
Savona 5
Da Nang 4
Florence 4
Karachi 4
Minneapolis 4
The Bronx 4
Verona 4
Baku 3
Beloit 3
Buenos Aires 3
Chula Vista 3
Denver 3
Des Moines 3
Hays 3
Jacksonville 3
Miami 3
Montreal 3
Nairobi 3
Oklahoma City 3
Orem 3
Orlando 3
Pittsburgh 3
Seattle 3
Tampa 3
Vancouver 3
Warsaw 3
Washington 3
Albenga 2
Belize City 2
Bologna 2
Brentwood 2
Brooklyn 2
Bình Dương 2
Bắc Ninh 2
Carcare 2
Castel Boglione 2
Cincinnati 2
City of London 2
Corona 2
Defiance 2
Dhaka 2
Dublin 2
Edgewater 2
Edgewood 2
Elk Grove Village 2
Erbil 2
Fort Wayne 2
Gilroy 2
Grand Rapids 2
Herriman 2
Hải Dương 2
Johannesburg 2
Maracaibo 2
Memphis 2
Menifee 2
Monticello 2
Naples 2
New Orleans 2
Ninh Bình 2
Nuremberg 2
Oakland 2
Phủ Lý 2
Queens 2
Totale 3.309
Nome #
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 354
Dysimmune mononeuropathies: A diagnosis not to be missed 239
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 151
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 138
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series 132
Regional variation of Guillain-Barré syndrome 132
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 128
FDG-PET and ASL MRI identify largely overlapping hypermetabolic and hyperperfusion changes in limbic autoimmune encephalitis 127
NERVE ULTRASOUND AND 3-TESLA MAGNETIC RESONANCE IMAGING FINDINGS IN NODO-PARANODOPATHIES: CORRELATION WITH CLINICAL AND NEUROPHYSIOLOGICAL EXAMINATIONS 126
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 123
High-resolution ultrasound and superb microvascular imaging findings in a case of post-COVID-19 vaccine parsonage-turner syndrome with multiple nerves involvement 122
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis 122
ATYPICAL STIFF PERSON SYNDROME WITH ANTI-IGLON5 ANTIBODIES: A CASE REPORT 116
An aggressive form of MOGAD treated with aHSCT: A case report 116
WHAT MAINTENANCE THERAPY TO PERFORM IN PATIENTS WITH ANTI-MAG NEUROPATHY AFTER THE FIRST CYCLE OF RITUXIMAB? A COMPARISON BETWEEN TWO REGIMENS 109
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 109
N-methyl-D-aspartate receptor antibody-related pathologies and pre-existent mental state disorders 104
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 102
I can’t count, but I can beat you playing cards: a case report on autoimmune encephalitis 96
Are basketball players more likely to develop Hirayama disease? 92
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments 90
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 90
Impact of environmental factors and physical activity on disability and quality of life in CIDP 89
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies 86
Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report 85
Imaging for inflammatory neuropathies. 83
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 81
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 80
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 75
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 74
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis 73
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 72
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score 71
Patient With Rigidity and Fasciculations 62
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 61
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 56
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses 50
Improving laboratory diagnostics in myasthenia gravis 49
null 48
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 45
null 44
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome 43
null 41
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 38
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. 37
Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis 15
Cervical alterations in Hirayama disease: an MRI and FDG-PET combined approach 14
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 14
Totale 4.404
Categoria #
all - tutte 15.180
article - articoli 15.180
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 16 2 0 4 9 12 11 29 22 18 6 26
2022/2023207 15 24 3 26 11 37 2 15 39 4 29 2
2023/2024313 13 14 23 66 12 58 22 26 10 13 15 41
2024/20251.129 61 61 25 93 107 91 90 196 71 65 148 121
2025/20262.196 265 56 105 124 261 86 235 108 161 188 492 115
2026/2027168 168 0 0 0 0 0 0 0 0 0 0 0
Totale 4.404